Multifocal Signal Modulation Therapy by Celecoxib: A Strategy for Managing Castration-Resistant Prostate Cancer

Background: Prostate cancer (PCa) is a significant health concern throughout the world. Standard therapy for advanced disease consists of anti-androgens, however, almost all prostate tumors become castration resistant (CRPC). Progression from androgen-sensitive PCa to CRPC is promoted by inflammator...

Descripción completa

Detalles Bibliográficos
Autores principales: Benelli, Roberto, Barboro, Paola, Costa, Delfina, Astigiano, Simonetta, Barbieri, Ottavia, Capaia, Matteo, Poggi, Alessandro, Ferrari, Nicoletta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6929142/
https://www.ncbi.nlm.nih.gov/pubmed/31816863
http://dx.doi.org/10.3390/ijms20236091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6929142/
https://www.ncbi.nlm.nih.gov/pubmed/31816863
http://dx.doi.org/10.3390/ijms20236091

Ejemplares similares